Nelso Obus, Wynnefield Capital Further Increase Holding Of Nature’s Sunshine Prod. (NATR)

Nelson Obus, the manager of Wynnefield Capital, is still optimistic about the prospects of Nature’s Sunshine Prod. (NASDAQ:NATR) and has increased his fund’s holding of the stock. According to a recent Form 4 filing with the Securities and Exchange Commission, Wynnefield Capital has added 20,851 Nature’s Sunshine Prod. (NASDAQ:NATR) shares to its portfolio in 9 transactions at prices varying between $15.96 and $16.04. Following this move, Obus and Wynnefield Capital have amassed 1.69 million shares.

Nelson Obus

Nature’s Sunshine Prod. (NASDAQ:NATR) has also attracted the attention of Phil Frohlich. His fund, Prescott Group Capital Management, holds 1.86 million shares, as reported in its latest 13F filing. Willem Mesdag is also a fan of this stock and has built a 2.43 million shares position for his fund, Red Mountain Capital. This position also accounts for 10.65% of Red Mountain’s equity portfolio. A somewhat smaller stake is held by Jim Simons and his fund, Renaissance Technologies: approximately 123,000 shares.

Disclosure: none.

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!